---
title: "Cognex (CGNX) Stock Could Be 13.3% Undervalued After Zacks Rank Upgrade"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290329722.md"
description: "Cognex (CGNX) was upgraded to Zacks Rank #1 (Strong Buy) due to higher consensus earnings estimates for its machine vision business. Despite strong recent share price momentum, the stock is considered potentially undervalued by some narratives, with a fair value of $76.25 against a current price of $66.10. However, high P/E ratios and competition in China pose risks."
datetime: "2026-06-20T14:55:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290329722.md)
  - [en](https://longbridge.com/en/news/290329722.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290329722.md)
generator: "portal-rs"
---

# Cognex (CGNX) Stock Could Be 13.3% Undervalued After Zacks Rank Upgrade

Cognex (CGNX) has moved into focus after being added to the Zacks Rank #1 (Strong Buy) list, a shift driven by a higher consensus earnings estimate for its machine vision business.

See our latest analysis for Cognex.

Cognex’s recent earnings estimate upgrade and macro driven swings have come against a backdrop of strong share price momentum, with a 90 day share price return of 34.24% and a 1 year total shareholder return of 124.77%. This suggests recent optimism is building on an already strong run.

If Cognex’s move has you thinking about what else is setting up for growth in automation, it could be a good moment to review 31 robotics and automation stocks

With Cognex trading at $66.10 against an analyst price target of $76.25 and some data pointing to modest overvaluation, the key question is clear: is there still an opportunity here, or is future growth already reflected in the price?

## Most Popular Narrative: 13.3% Undervalued

With Cognex shares at $66.10 against a most-followed fair value of $76.25, the current price sits below what that narrative implies.

> *Accelerating adoption of AI-powered vision solutions (as seen with OneVision and the shift to cloud-based, scalable deployment) positions Cognex to upsell higher-value systems and increase average selling prices, supporting higher revenue and gross margin expansion.*

*Read the complete narrative.* Read the complete narrative.

Want to understand why this valuation leans higher than today’s share price? The story hinges on faster earnings growth, richer margins, and a premium multiple usually reserved for sector leaders.

**Result: Fair Value of $76.25 (UNDERVALUED)**

Have a read of the narrative in full and understand what's behind the forecasts.

However, Cognex’s fair value story still faces pressure from hardware commoditization and intense competition in China, which could squeeze pricing power and future margins.

Find out about the key risks to this Cognex narrative.

## Another View: Cognex Through the P/E Lens

The fair value narrative for Cognex at $76.25 points to upside, but the market’s current P/E of 77.2x tells a tougher story. That multiple sits well above the US Electronic industry on 32.9x and a fair ratio of 42.6x, which raises the question of how much optimism is already in the price.

For a closer look at how that gap between the current P/E, peers, and the fair ratio could affect potential upside or downside, it is worth going through the full valuation breakdown in detail, See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:CGNX P/E Ratio as at Jun 2026

## Next Steps

Given the mixed signals around Cognex’s valuation, it makes sense to review the numbers yourself and weigh both the upside and the downside. To see how investors are balancing potential rewards with the risks on their radar, check out the 2 key rewards and 1 important warning sign

## Looking for more ideas beyond Cognex?

If Cognex has sharpened your interest in opportunities, do not stop here. Use targeted screens to uncover other stocks that could fit your portfolio goals.

-   Target potential mispricings by reviewing companies that appear attractively valued on fundamentals using our 45 high quality undervalued stocks.
-   Strengthen your income stream by focusing on companies with higher dividend yields through the 8 dividend fortresses.
-   Prioritise resilience by filtering for businesses with healthier balance sheets and robust fundamentals using the solid balance sheet and fundamentals stocks screener (48 results).

 *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.*

### **New:** AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)  
• Undervalued Small Caps with Insider Buying  
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

### Related Stocks

- [CGNX.US](https://longbridge.com/en/quote/CGNX.US.md)

## Related News & Research

- [Allianz Asset Management GmbH Invests $7.85 Million in Cognex Corporation $CGNX](https://longbridge.com/en/news/298412767.md)
- [Cognex declares R$ 0.04 dividend per unit for Q3 2026](https://longbridge.com/en/news/298326989.md)
- [Is Cognex (CGNX) Stock Too Rich After Its 64% Rally?](https://longbridge.com/en/news/295821082.md)
- [Is First Advantage (FA) A Bargain As Its Zacks Upgrade Lifts Earnings Hopes?](https://longbridge.com/en/news/298537629.md)
- [Is Zacks’ Upgrade of Esquire Financial (ESQ) Reframing the Bank’s Legal-Finance Earnings Narrative?](https://longbridge.com/en/news/298128086.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**